7 Old age psychiatry7.4 Psychiatric aspects of physical disease
7.4 Physical disease and psychiatric presentation in later life
7 min read3 figures
Written by Resident Doctor Committee · Published
How physical and psychiatric illness interact
Physical disease can act on the brain directly (stroke, endocrine illness), through its treatment (corticosteroids, dopaminergic drugs), or through loss, pain and dependence.
Depression in turn worsens nutrition, mobility, adherence and self-care.
Normal sadness about illness varies with circumstances and allows enjoyment, but no single pattern excludes depression, so assess persistence, anhedonia, guilt and suicidality.
Normal ageing
System | Change with age |
|---|---|
Brain | Tissue shrinks, so the ventricles and sulci enlarge; the hippocampus shrinks and cerebral blood flow falls |
Body composition | Lean muscle mass and total body water fall; the proportion of body fat rises |
Eye | The lens thickens rather than thins |
Kidney | Renal blood flow and glomerular filtration fall, even in healthy people |
Memory | Self-initiated retrieval (free recall) declines clearly; recognition, semantic knowledge and eventual mastery of new material are relatively spared |
Renally excreted drugs accumulate in older people because glomerular filtration declines.
Blood results that mislead
A normal serum creatinine can hide a reduced filtration rate, because less muscle produces less creatinine.
Low albumin lowers measured total calcium (pseudohypocalcaemia) and raised albumin raises it, because much plasma calcium is albumin bound while ionised calcium stays normal.
Prescribing hazards in older people
Polypharmacy, the cumulative effect of many regular medicines, causes falls and gait disturbance.
Antidepressants are the psychotropic class most strongly linked to falls, and selective serotonin reuptake inhibitors (SSRIs) raise falls risk about as much as tricyclics, despite their cardiac and anticholinergic advantages.
SSRIs raise upper gastrointestinal bleeding risk by depleting platelet serotonin and impairing aggregation, adding to the risk from aspirin, non-steroidal anti-inflammatory drugs (NSAIDs) and anticoagulants.
Ginkgo biloba raises bleeding risk additively, so people taking an anticoagulant or antiplatelet drug should avoid it.
Aminophylline, theophylline and acetazolamide reduce proximal tubular sodium reabsorption, which increases lithium excretion and lowers the serum level.
Thiazides, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers and NSAIDs raise the serum lithium level.
Older age is a strong, dose-independent risk factor for tardive dyskinesia, raising its incidence five- to six-fold compared with younger adults on the same antipsychotic.
Benzodiazepines can cause paradoxical disinhibition in older adults, with excitement, hostility, vivid dreams and sexual disinhibition alongside sedation.
Antipsychotics, stroke and the heart
Antipsychotics in older adults roughly double the rate of stroke and other cerebrovascular events (rate ratio about 1.7, confidence interval about 1.6 to 1.9), with a similar excess for typical and atypical drugs.
Douglas and Smeeth (2008) found a rate ratio of about 2.3 for atypicals.
In dementia, antipsychotics raise stroke risk two- to threefold, an absolute risk near 1%, with the excess concentrated early in treatment.
In dementia trials, stroke risk with risperidone and olanzapine was about three times that with placebo.
UK regulatory warnings on excess mortality and stroke in dementia now cover all first- and second-generation antipsychotics, not only the two drugs first named in 2004.
Corrected QT interval (QTc) on combined psychotropics | Action |
|---|---|
440 to 500 ms | Reduce the dose and repeat the electrocardiogram |
Above 500 ms | Highest risk band: refer to cardiology immediately |
The National Institute for Health and Care Excellence (NICE) advises short-term, low-dose haloperidol for agitation in delirium when distress or risk to others persists after de-escalation fails, provided the QTc is normal and there is no parkinsonism.
Benzodiazepines are kept for withdrawal delirium.
Psychiatric effects of medicines for physical illness
Drug | Use in older people | Psychiatric effect |
|---|---|---|
High-dose dexamethasone | Cerebral oedema around brain metastases | Dose-related elation with little need for sleep, often within the first two weeks |
Levetiracetam | Post-stroke seizures | Irritability, aggression and depressed mood |
Oxybutynin | Urge incontinence | Memory worsening and evening disorientation, with dry mouth and constipation |
Ask about suicidal thoughts with any antiepileptic.
Oxybutynin is antimuscarinic and crosses the blood-brain barrier readily, so it harms people with existing cognitive impairment most.
Parkinson's disease
Depression, anxiety, apathy and psychosis are common, and anxiety or low mood may precede the motor diagnosis or worsen in "off" periods.
Apathy is reduced initiation and motivation, sometimes without sadness or guilt, so assess for coexisting depression.
Dementia risk rises with age and with duration of Parkinson's disease.
Impulse control disorders
Dopamine agonists acting at D2 and D3 receptors, such as pramipexole, are the drugs most strongly linked to impulse control disorders, in Parkinson's disease and in restless legs syndrome.
They act by stimulating the mesolimbic reward pathway, and risk rises with dose.
Levodopa has a weaker, dose-related association.
The behaviours are gambling, hypersexuality, compulsive buying and binge eating, affecting about one in six to one in five agonist-treated patients.
Punding is repetitive, non-goal-directed activity.
Ask before treatment and at each review, with collateral history, because patients may not see the link or may not disclose it.
Reduce the agonist gradually under specialist guidance, because abrupt withdrawal can cause a severe withdrawal syndrome.
Psychosis and other levodopa effects
Psychiatric effect of levodopa | Frequency |
|---|---|
Vivid dreams and nightmares (the commonest) | About 30% |
Night terrors | About 7% |
Delirium | About 5% |
Delusional syndrome | About 3% |
Visual experiences range from sensed presence or movement at the edge of vision to formed hallucinations and delusions.
Assess new symptoms for delirium, and review provoking drugs with a Parkinson's specialist; well-tolerated hallucinations may need no drug.
NICE suggests considering quetiapine where there is no cognitive impairment, and offering clozapine with its monitoring when standard treatment fails.
Avoid conventional antipsychotics and risperidone, which worsen motor function.
Stroke
Post-stroke depression
Routine SSRI treatment after stroke lowers the incidence of new depression but raises fracture risk and does not improve motor or functional recovery.
In placebo-controlled prevention trials, escitalopram, sertraline, fluoxetine and mirtazapine reduced post-stroke depression, but mianserin did not.
Situation | Preferred drug | Reason |
|---|---|---|
Raised gastrointestinal bleeding risk | Nortriptyline | Little effect on platelet serotonin; trial evidence in post-stroke depression |
Taking warfarin | Citalopram or escitalopram | Least effect on the cytochrome P450 enzymes that clear warfarin |
SSRIs, serotonin and noradrenaline reuptake inhibitors and serotonergic tricyclics all block the platelet serotonin transporter.
With warfarin, fluvoxamine and fluoxetine inhibit its clearing enzymes, carbamazepine induces them, and amitriptyline is also less suitable.
Emotionalism
Pseudobulbar affect is brief, stereotyped, uncontrollable laughing or crying that does not match the felt mood, arising from neurological disease.
Post-stroke emotionalism is brief, poorly controlled crying or laughing that can coexist with depression.
Feature | Emotionalism | Post-stroke depression |
|---|---|---|
Trigger | Minor or none | None needed |
Duration | Seconds to minutes | Sustained over weeks |
Fit with felt mood | Incongruent or excessive | Reflects low mood |
SSRI response | Rapid and independent of depression | Judged over weeks |
An SSRI is the first-line drug for emotionalism, with trial support; treat when it causes distress or limits rehabilitation.
Stroke may also cause executive dysfunction, apathy, rigidity or disinhibition, judged against premorbid behaviour.
Acute neurological presentations
Unenhanced computed tomography (CT) of the head is the first test for suspected subarachnoid haemorrhage, being fast and nearly fully sensitive in the first hours.
Lumbar puncture is kept for a normal CT with persisting suspicion.
Facial weakness | Forehead and eye closure | Lesion |
|---|---|---|
Upper motor neuron | Spared | Contralateral hemisphere |
Lower motor neuron | Involved | Ipsilateral facial nerve |
The forehead is spared in upper motor neuron weakness because the upper face has bilateral cortical supply.
Sensory impairment
Hearing and visual loss can mimic cognitive failure or suspiciousness, so check aids and adapt communication before interpreting test scores.
Charles Bonnet syndrome is formed visual hallucinations, often of people, animals or patterns, arising from sight loss in clear consciousness, with insight kept and no cognitive or psychiatric disorder.
Preserved insight alone does not exclude delirium or Lewy body disease.
Manage it with explanation, better vision and reassurance; antipsychotics have little evidence and their risks usually outweigh benefit.
Reversible contributors to dementia
A treatable cause more often overlaps with neurological disease than fully explains it.
Cause | Features |
|---|---|
Normal pressure hydrocephalus | Gait disturbance, urinary symptoms and cognitive slowing; the full triad need not be present; gait responds to shunting more than cognition |
Chronic subdural haematoma | Follows falls, especially on anticoagulants; fluctuating cognition and headache; an earlier scan does not exclude a later bleed |
Vitamin B12 deficiency | Affects cognition even without anaemia |
Hypothyroidism | Slows mood, thinking and movement |
Anticholinergic and sedative load | Bladder medicines, opioids and benzodiazepines; reduce cautiously |
Other causes include hyperparathyroidism, hypercalcaemia, uraemia, hepatic encephalopathy, neurosyphilis, human immunodeficiency virus (HIV) disease and autoimmune or limbic encephalitis.
A rapid course, early gait or sphincter change, focal signs, systemic symptoms or a link to a drug or injury should widen the work-up.